Stockreport

BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets [Yahoo! Finance]

BeiGene, Ltd. - American Depositary Shares  (BGNE) 
Last beigene, ltd. - american depositary shares earnings: 3/2 04:05 pm Check Earnings Report
PDF The data highlights the efficacy and safety of its drug BRUKINSA (zanubrutinib) and promising advancements in its pipeline assets, including sonrotoclax and BGB-16673. T [Read more]